Analytical Data
-
Gene name
IL-20R alpha
- Application
-
Alternative Names
IL20R1; ZCYTOR7; ZcytoR7; Cytokine receptor class-II member 8
-
Species
Human
-
Source
E. coli
-
Tag
N- His & GST
-
Purity
> 90% as determined by SDS-PAGE.
-
Uniprot
Q9UHF4
-
Expression Region
Met269~Trp545
-
Molecular Weight
61kDa
-
Endotoxin
< 1.0 EU per μg protein as determined by the LAL method.
-
Form
Freeze-dried powder
-
Buffer formulation
PBS, pH7.4, containing 0.01% SKL, 1mM DTT, 5% Trehalose and Proclin300.
-
Reconstitution
Reconstitute in ddH2O to a concentration of 0.1-0.5 mg/mL. Do not vortex.
- Customization
-
Stability Test
The thermal stability is described by the loss rate. The loss rate was determined by accelerated thermal degradation test, that is, incubate the protein at 37℃ for 48h, and no obvious degradation and precipitation were observed. The loss rate isless than 8% within the expiration date under appropriate storage condition.
-
Storage & Shelf Life
Samples are stable for up to twelve months from date of receipt at -20℃ to -80℃. Store it under sterile conditions at -20℃ to -80℃. It is recommended that the protein be aliquoted for optimal storage. Avoid repeated freeze-thaw cycles.
-
Shipping
In general, recombinant proteins are supplied as lyophilized powder and shipped at ambient temperature. For bulk packages, the proteins are provided as frozen liquid and shipped with blue ice, unless otherwise requested by the customer.
Quality inspection process
Related Products
Protein Description
IL-20R alpha, also known as IL-20 receptor subunit alpha, is a key component of the interleukin-20 receptor complex, which plays a crucial role in various physiological and pathological processes, particularly in the context of immune regulation and inflammation. Research has shown that IL-20R alpha is involved in the signaling pathways associated with skin disorders, such as psoriasis and atopic dermatitis, as well as in the modulation of inflammatory responses in other tissues. Its interaction with IL-20 and other cytokines suggests that IL-20R alpha may be a potential therapeutic target for treating inflammatory diseases. The recombinant protein of IL-20R alpha is of significant interest for various applications, including basic research, drug development, and as a potential biomarker for disease. By studying the recombinant form, researchers aim to unravel the molecular mechanisms underlying its function, explore its interactions with ligand proteins, and assess its role in immune responses. Furthermore, the availability of a recombinant IL-20R alpha can facilitate high-throughput screening of potential inhibitors or activators, contributing to the development of novel therapeutic strategies. Understanding the biology of IL-20R alpha can provide insights into how modulation of this receptor may lead to improved treatments for patients suffering from inflammatory and autoimmune conditions. Thus, ongoing research in this area holds promise for the advancement of targeted therapies and better management of related diseases.
